Unseld M, Belic J, Pierer K, Zhou Q, et al. A higher ctDNA fraction decreases survival in regorafenib-treated metastatic colorectal cancer patients. Results from the regorafenib's liquid biopsy (RELAIS) translational biomarker phase II pilot study. Int J Cancer 2020 Sep 19. doi: 10.1002/ijc.33303.
PMID: 32949150